Rajat Rohatgi

Rajat Rohatgi

Auto-generated profile, based on publicly available information

Rajat Rohatgi

Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Genes & Development
Verified
Journal Article
Closed access
PDF file
EHEric W. Humke
Eric W. Humke
KDKarolin V. Dorn
Karolin V. Dorn
LMLjiljana Milenkovic
Ljiljana Milenkovic
MSMatthew P. Scott
Matthew P. Scott
RRRajat Rohatgi
Rajat Rohatgi
The transcriptional program orchestrated by Hedgehog signaling depends on the Gli family of transcription factors. Gli proteins can be converted to either transcriptional activators or truncated transcriptional repressors. We show that the interaction between Gli3 and Suppressor of Fused (Sufu) regulates the formation of either repressor or activator forms of Gli3. In the absence of signaling, Sufu restrains Gli3 in the cytoplasm, promoting its processing into a repressor. Initiation of signaling triggers the dissociation of Sufu from Gli3. This event prevents formation of the repressor and instead allows Gli3 to enter the nucleus, where it is converted into a labile, differentially phosphorylated transcriptional activator. This key dissociation event depends on Kif3a, a kinesin motor required for the function of primary cilia. We propose that the Sufu–Gli3 interaction is a major control point in the Hedgehog pathway, a pathway that plays important roles in both development and cancer.

4 March 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ACAlexander E. Conicella
Alexander E. Conicella
GDGregory L. Dignon
Gregory L. Dignon
GZGül H. Zerze
Gül H. Zerze
HSHermann Broder Schmidt
Hermann Broder Schmidt
ADAlexandra M. D’ordine
Alexandra M. D’ordine
NFNicolas L. Fawzi
Nicolas L. Fawzi
Liquid–liquid phase separation (LLPS) is involved in the formation of membraneless organelles (MLOs) associated with RNA processing. The RNA-binding protein TDP-43 is present in several MLOs, undergoes LLPS, and has been linked to the pathogenesis of amyotrophic lateral sclerosis (ALS). While some ALS-associated mutations in TDP-43 disrupt self-interaction and function, here we show that designed single mutations can enhance TDP-43 assembly and function via modulating helical structure. Using molecular simulation and NMR spectroscopy, we observe large structural changes upon dimerization of TDP-43. Two conserved glycine residues (G335 and G338) are potent inhibitors of helical extension and helix–helix interaction, which are removed in part by variants at these positions, including the ALS-associated G335D. Substitution to helix-enhancing alanine at either of these positions dramatically enhances phase separation in vitro and decreases fluidity of phase-separated TDP-43 reporter compartments in cells. Furthermore, G335A increases TDP-43 splicing function in a minigene assay. Therefore, the TDP-43 helical region serves as a short but uniquely tunable module where application of biophysical principles can precisely control assembly and function in cellular and synthetic biology applications of LLPS.

20 July 2016 in Nature
Verified
Journal Article
Open access
PDF file
EBEamon F. X. Byrne
Eamon F. X. Byrne
RSRia Sircar
Ria Sircar
PMPaul S. Miller
Paul S. Miller
GHGeorge Hedger
George Hedger
GLGiovanni Luchetti
Giovanni Luchetti
CSChristian Siebold
Christian Siebold
Structural studies show that the activity of the G-protein-coupled receptor Smoothened is modulated by ligand-regulated interactions between its extracellular and transmembrane domains. Developmental signals of the Hedgehog (Hh) and Wnt families are transduced across the membrane by Frizzled-class G-protein-coupled receptors (GPCRs) composed of both a heptahelical transmembrane domain (TMD) and an extracellular cysteine-rich domain (CRD). How the large extracellular domains of GPCRs regulate signalling by the TMD is unknown. We present crystal structures of the Hh signal transducer and oncoprotein Smoothened, a GPCR that contains two distinct ligand-binding sites: one in its TMD and one in the CRD. The CRD is stacked atop the TMD, separated by an intervening wedge-like linker domain. Structure-guided mutations show that the interface between the CRD, linker domain and TMD stabilizes the inactive state of Smoothened. Unexpectedly, we find a cholesterol molecule bound to Smoothened in the CRD binding site. Mutations predicted to prevent cholesterol binding impair the ability of Smoothened to transmit native Hh signals. Binding of a clinically used antagonist, vismodegib, to the TMD induces a conformational change that is propagated to the CRD, resulting in loss of cholesterol from the CRD–linker domain–TMD interface. Our results clarify the structural mechanism by which the activity of a GPCR is controlled by ligand-regulated interactions between its extracellular and transmembrane domains. Smoothened (SMO) is a G-protein-coupled receptor that transduces Hedgehog (Hh) signals across the membrane in all animals. Despite being a key developmental regulator, oncoprotein and drug target in oncology, the mechanism by which SMO is activated has remained unknown. These authors solve the 3.2 Å crystal structure of SMO containing its extracellular cysteine-rich (CRD), linker and heptahelical G-protein-coupled receptor (TMD) domains. Surprisingly, a cholesterol molecule was bound to SMO in the CRD binding site. Mutations predicted to prevent cholesterol binding impair the ability of SMO to transmit native Hh signals. Binding of the potent antagonist and anti-cancer drug vismodegib leads to a number of conformational changes and the loss of cholesterol from the CRD–linker domain–TMD interface.

26 October 2009 in Journal of Cell Biology
Verified
Journal Article
Open access
LMLjiljana Milenkovic
Ljiljana Milenkovic
MSMatthew P. Scott
Matthew P. Scott
RRRajat Rohatgi
Rajat Rohatgi
The function of primary cilia depends critically on the localization of specific proteins in the ciliary membrane. A major challenge in the field is to understand protein trafficking to cilia. The Hedgehog (Hh) pathway protein Smoothened (Smo), a 7-pass transmembrane protein, moves to cilia when a ligand is received. Using microscopy-based pulse-chase analysis, we find that Smo moves through a lateral transport pathway from the plasma membrane to the ciliary membrane. Lateral movement, either via diffusion or active transport, is quite distinct from currently studied pathways of ciliary protein transport in mammals, which emphasize directed trafficking of Golgi-derived vesicles to the base of the cilium. We anticipate that this alternative route will be used by other signaling proteins that function at cilia. The path taken by Smo may allow novel strategies for modulation of Hh signaling in cancer and regeneration.

8 January 2012 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
SNSigrid Nachtergaele
Sigrid Nachtergaele
LMLaurel K Mydock
Laurel K Mydock
KKKathiresan Krishnan
Kathiresan Krishnan
JRJayan Rammohan
Jayan Rammohan
PSPaul H Schlesinger
Paul H Schlesinger
RRRajat Rohatgi
Rajat Rohatgi
20(S)-hydroxycholesterol binds to Smo at a site distinct from cyclopamine and activates signaling via an allosteric mechanism. A new alkyne oxysterol analog selectively captures Smo from membrane extracts and provides a new method for detecting protein-sterol interactions. Oxysterols are a class of endogenous signaling molecules that can activate the Hedgehog pathway, which has critical roles in development, regeneration and cancer. However, it has been unclear how oxysterols influence Hedgehog signaling, including whether their effects are mediated through a protein target or indirectly through effects on membrane properties. To answer this question, we synthesized the enantiomer and an epimer of the most potent oxysterol, 20(S)-hydroxycholesterol. Using these molecules, we show that the effects of oxysterols on Hedgehog signaling are exquisitely stereoselective, consistent with the hypothesis that they function through a specific protein target. We present several lines of evidence that this protein target is the seven-pass transmembrane protein Smoothened, a major drug target in oncology. Our work suggests that these enigmatic sterols, which have multiple effects on cell physiology, may act as ligands for signaling receptors and provides a generally applicable framework for probing sterol signaling mechanisms.

1 January 2014 in Cell Reports
Verified
Journal Article
Open access
PNPaweł Niewiadomski
Paweł Niewiadomski
JKJennifer H. Kong
Jennifer H. Kong
RARobert Ahrends
Robert Ahrends
YMYan Ma
Yan Ma
EHEric W. Humke
Eric W. Humke
RRRajat Rohatgi
Rajat Rohatgi
Gli proteins are transcriptional effectors of the Hedgehog (Hh) pathway in both normal development and cancer. We describe a program of multisite phosphorylation that regulates the conversion of Gli proteins into transcriptional activators. In the absence of Hh ligands, Gli activity is restrained by the direct phosphorylation of six conserved serine residues by protein kinase A (PKA), a master negative regulator of the Hh pathway. Activation of signaling leads to a global remodeling of the Gli phosphorylation landscape: the PKA target sites become dephosphorylated, while a second cluster of sites undergoes phosphorylation. The pattern of Gli phosphorylation can regulate Gli transcriptional activity in a graded fashion, suggesting a phosphorylation-based mechanism for how a gradient of Hh signaling in a morphogenetic field can be converted into a gradient of transcriptional activity.